Andrew Serafin - 24 Jan 2025 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Role: CHIEF STRATEGY OFFICER
Signature: /s/ Christian Ulrich, Attorney-in-Fact
Issuer symbol: HRMY
Transactions as of: 24 Jan 2025
Net transactions value: -$32,879
Form type: 4
Filing time: 28 Jan 2025, 12:51:34 UTC
Previous filing: 26 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HRMY	Common Stock	Options Exercise	$0	+2,500		$0.000000	2,500	24 Jan 2025	Direct
transaction	HRMY	Common Stock	Tax liability	$32,879	-865	-35%	$38.01	1,635	24 Jan 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HRMY	Restricted Stock Units	Options Exercise	$0	-2,500	-25%	$0.000000	7,500	24 Jan 2025	Common Stock	2,500		Direct	F2
transaction	HRMY	Stock Option	Award	$0	+36,500		$0.000000	36,500	25 Jan 2025	Common Stock	36,500	$38.01	Direct	F3
transaction	HRMY	Restricted Stock Units	Award	$0	+10,400		$0.000000	10,400	25 Jan 2025	Common Stock	10,400		Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.
F2	This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.
F3	The stock option vests with respect to 25% of the underlying shares on January 25, 2026, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
F4	The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.